跳至主要内容
临床试验/NL-OMON38104
NL-OMON38104已完成不适用

Prevention of CF exacerbation in childhood (PREVEC-study): early recognition by non-invasive biomarkers in exhaled breath (condensate) and early antibiotic treatment - Prevention of CF exacerbations in childhood (PREVEC-study)

Medisch Universitair Ziekenhuis Maastricht0 个研究点目标入组 49 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
49

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
2 至 17(—)

入选标准

  • Children with CF aged 5-18 years will be recruited.
  • CF disease is defined as the combination of: 1) characteristic clinical features (persistent pulmonary symptoms, meconium ileus, failure to thrive, steatorrhoe); 2) and/or abnormal sweat test (chloride > 60mM); 3) and/or two CF mutations.

排除标准

  • Exclusion criteria are: 1) cardiac abnormalities; 2) mental retardation; 3) no technical satisfactory performance of measurements; 4) on the waiting list for lung transplantation; 5) non-compliance with the home-assessments; 6) patients with Burkholderia Cepacia; 7) participation in another intervention trial.

研究者

发起方
Medisch Universitair Ziekenhuis Maastricht

相似试验

Prevention of CF exacerbation in childhood... | 临床试验